Dabur Pharma gets FDA nod for cancer drug
Indian drug maker Dabur Pharma Ltd. has received approval from the US Food and Drug Administration for oncology drug paclitaxel injections, the regulatory agency's Web site showed.
bdnews24.com News Service
bdnews24.com
Published :
06 Dec 2006, 06:00 PM
Updated :
17 Aug 2022, 06:58 PM
MUMBAI, December 6 (bdnews24.com/Reuters) - Indian drug maker Dabur Pharma Ltd. has received approval from the US Food and Drug Administration for oncology drug paclitaxel injections, the regulatory agency's Web site showed.
Paclitaxel is the generic equivalent of Bristol-Myers Squibb Co.'s Taxol, used in treating ovarian and breast cancer.
bdnews24.com/mhb/1408 hrs